# Shelley Margetson

> Shelley Margetson is a seed investor at V-Bio Ventures backing Medical and Clinical Trials. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [V-Bio Ventures](https://shizune.co/investors/profile/v-bio-ventures)
- Total investments: 1
- Last investment: Aug 2022
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/shelley-margetson-b5386138/

Shelley Margetson is a seed investor at V-Bio Ventures focused on Medical and Clinical Trials. Shelley Margetson is the Managing Partner at V-Bio Ventures. She attended INSEAD.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Clinical Trials | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| AstriVax | AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline. | $29.9M | Seed | Aug 25, 2022 |  |

1 of 1 investments shown.

## Co-investors
- [Ackermans & van Haaren](https://shizune.co/investors/profile/ackermans-van-haaren) — VC Fund, 1 deal together
- [BNP Paribas Fortis](https://shizune.co/investors/profile/bnp-paribas-fortis) — VC Fund, 1 deal together
- [Flanders Future Techfund](https://shizune.co/investors/profile/flanders-future-techfund) — VC Fund, 1 deal together
- [Fund+](https://shizune.co/investors/profile/fund) — VC Fund, 1 deal together
- [Gemma Frisius Fund](https://shizune.co/investors/profile/gemma-frisius-fund) — VC Fund, 1 deal together
- [Mérieux Equity Partners](https://shizune.co/investors/profile/merieux-equity-partners) — VC Fund, 1 deal together

## About V-Bio Ventures

VC Fund · Gent, Belgium

V-Bio Ventures is an independent venture capital firm specialized in building and financing young, innovative life science companies. The fund invests throughout Europe in start-up and early-stage companies with high growth potential focusing on technologies that provide transformational improvements in the biotech, pharmaceutical and agriculturalsectors.

4 contacts available at V-Bio Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Shelley Margetson | Managing Partner | https://shizune.co/investors/profile/shelley-margetson |
| Willem Broekaert | Managing Partner | https://shizune.co/investors/profile/willem-broekaert |
| Christina Takke | Managing Partner | https://shizune.co/investors/profile/christina-takke |
| Ward Capoen | Partner | https://shizune.co/investors/profile/ward-capoen |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Shelley Margetson invest in?

Shelley Margetson invests primarily in Medical and Clinical Trials startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Shelley Margetson last invest?

The most recent investment recorded for Shelley Margetson closed in Aug 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co